Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001466220 | SCV001670220 | likely benign | Gastrointestinal stromal tumor; Paragangliomas 4; Pheochromocytoma | 2024-06-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002405092 | SCV002707851 | likely benign | Hereditary cancer-predisposing syndrome | 2021-04-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV004809622 | SCV005435384 | likely benign | not provided | 2024-09-01 | criteria provided, single submitter | clinical testing | SDHB: BP4, BP7 |